STOCK TITAN

Cadre Holdings (CDRE) SEC Filings, Jun-Aug 2026

CDRE NYSE

Cadre Holdings, Inc. SEC filings document the company's safety-equipment business, public-company governance and NYSE-listed common stock. Form 8-K reports cover operating results, financial condition, Regulation FD presentations, material events and related exhibits for its law enforcement, first responder, military and nuclear safety markets.

Cadre's filings also include proxy materials for annual meeting matters, board and stockholder voting procedures, and corporate governance disclosures. Financial-result filings discuss GAAP measures alongside non-GAAP metrics such as EBITDA, adjusted EBITDA and adjusted EBITDA margin, while event reports address material agreements, acquisition-related communications, capital-structure disclosures and security registration details for CDRE common stock.

Rhea-AI Summary

Cadre Holdings, Inc. (CDRE) is the issuer named in officer Brad Williams’s notice of a proposed sale of 88,742 common shares, with an aggregate market value of $3,029,651.88 and an approximate sale date of August 17, 2026. The listed acquisitions were 42,770 and 45,972 shares, each acquired from the issuer through a cash-paid stock-option exercise dated August 17, 2026. UBS Financial Services Inc. is named as broker; Mijo Suric signed as its attorney-in-fact for Brad Williams.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.45%
Tags
other
-
EFFECT
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.18%
Tags
other
-
Rhea-AI Summary

Cadre Holdings, Inc. filed an amended report to correct an error in the calculation of its last twelve months adjusted EBITDA in previously released Q2 2026 materials; underlying operating results are unchanged. For the quarter ended June 30, 2026, net sales were $207.1 million, up 32% from $157.1 million a year earlier, and gross profit was $87.1 million, up 36%.

Gross margin improved to 42.1%. Net income was $11.4 million versus $12.2 million, as higher contingent consideration, compensation and foreign exchange impacts offset stronger gross profit. Adjusted EBITDA rose to $42.0 million, with margin expanding to 20.3%. Orders backlog reached a record $368 million. Management raised its 2026 outlook to net sales of $749–$769 million and adjusted EBITDA of $139–$144 million, with expected capital expenditures of $10–$14 million.

For the first half of 2026, operating cash flow increased to $44.7 million, while business acquisitions of $163.9 million contributed to higher total debt and reduced cash and restricted cash to $57.7 million. The company highlighted an FBI-related ballistic armor IDIQ contract opportunity, the Alien Gear Holsters acquisition, and a quarterly dividend of $0.10 per share.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.18%
Tags
current report
Rhea-AI Summary

FMR LLC filed an amended Schedule 13G reporting beneficial ownership of 2,475,622.54 shares of Cadre Holdings, Inc. common stock, representing 5.8% of the class. FMR reports sole dispositive power over all of these shares and sole voting power over 2,475,549 shares, with no shared voting or dispositive power.

Abigail P. Johnson is also listed as a reporting person, with sole dispositive power over the same 2,475,622.54 shares. One or more other persons have rights to dividends or sale proceeds from these securities, but no such person holds more than five percent of the outstanding common stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
12.86%
Tags
ownership
-
Rhea-AI Summary

Cadre Holdings, Inc. has filed Amendment No. 1 to a Form S-4 acquisition shelf registration covering 7,500,000 shares of common stock, par value $0.0001 per share. These shares may be issued from time to time as stock consideration in negotiated acquisitions of assets, businesses or securities, potentially alongside cash, notes, assumption of liabilities or other consideration. Cadre states it does not expect to receive cash proceeds from this offering other than the value of acquired assets or businesses. The common stock is listed on the NYSE under symbol CDRE, and the last reported price was $30.83 per share on July 31, 2026. As context, Cadre is authorized to issue 190,000,000 shares of common stock and 10,000,000 shares of preferred stock, with 42,797,451 common shares outstanding as of July 31, 2026, and currently pays a $0.10 quarterly dividend ($0.40 annualized). The amendment primarily updates the prospectus, filing fee table, and auditor consent while preserving Cadre’s flexibility to use equity as acquisition currency.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
12.86%
Tags
registration
-
Rhea-AI Summary

Cadre Holdings, Inc. reported strong top-line growth for the three and six months ended June 30, 2026. Net sales rose to $207.1 million for the quarter, up 31.8% from $157.1 million, and to $362.6 million year-to-date, up 26.2%. Gross profit reached $87.1 million for the quarter. Operating income increased to $22.5 million, while quarterly net income edged down to $11.4 million from $12.2 million as higher contingent consideration, compensation, interest expense and adverse foreign currency effects offset margin gains. Adjusted EBITDA grew to $42.0 million in the quarter and $63.1 million year-to-date.

The company accelerated its acquisition strategy, closing the $185.2 million TYR Tactical deal and the $10.3 million Alien Gear holsters acquisition, expanding the Product segment and increasing goodwill and intangibles to $408.1 million. Total assets rose to $917.3 million, funded partly by higher term debt of $375.9 million, while cash, cash equivalents and restricted cash declined to $57.7 million. Orders backlog nearly doubled to $367.7 million, supported by large orders for blast attenuation seats, sensors, remotely operated vehicles, nuclear safety products and duty gear holsters, providing visibility into future revenue.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
12.86%
Tags
quarterly report
Rhea-AI Summary

Cadre Holdings reported strong Q2 2026 results, with net sales of $207.1 million up from $157.1 million a year earlier and gross profit rising to $87.1 million. Adjusted EBITDA increased to $42.0 million with a 20.3% margin versus 17.2%, while net income was $11.4 million compared with $12.2 million. For the first half of 2026, net sales reached $362.6 million versus $287.2 million and adjusted EBITDA was $63.1 million, but net income declined to $13.4 million from $21.5 million.

Orders backlog reached a record $368 million, supporting an increased 2026 outlook for net sales of $749–$769 million and adjusted EBITDA of $139–$144 million, with expected capital expenditures of $10–$14 million. The company completed the acquisition of Alien Gear Holsters, highlighted Safariland’s role in a five‑year, $61.0 million FBI IDIQ armor program, and declared a quarterly cash dividend of $0.10 per share. Cash, cash equivalents and restricted cash totaled $57,669 thousand at June 30, 2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
12.86%
Tags
current report
-
Rhea-AI Summary

Cadre Holdings, Inc. amended and restated its Canadian revolving credit facility, allowing its Canadian subsidiaries Med-Eng Holdings ULC, Pacific Safety Products Inc., ICOR Technology Inc. and TYR Tactical Canada ULC to borrow up to CDN$20.0 million, including up to CDN$6.0 million for letters of credit. The Revolving Canadian Loan matures on December 20, 2029 and is guaranteed by Safariland, LLC.

Borrowings may be in U.S. or Canadian dollars and bear interest at base rate, SOFR, Canadian Prime Rate or CORRA benchmarks plus margins ranging from 0.50% to 2.50% per annum, depending on Cadre’s consolidated total net leverage ratio. An unused line fee of 0.175% to 0.25% per annum applies, and the agreement includes customary covenants and events of default.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.20%
Tags
current report
-
Rhea-AI Summary

Cadre Holdings, Inc. insider Warren B. Kanders, through affiliated entity Kanders SAF, LLC, reported open-market sales of a total of 75,000 shares of Common Stock. On June 18, Kanders SAF, LLC sold 25,000 shares at a weighted average price of $27.86 per share, in multiple trades within a $27.49–$28.42 range. On June 22, it sold an additional 50,000 shares at a weighted average price of $27.43 per share, with individual trades between $27.28–$27.67. Following these transactions, Kanders SAF, LLC held 9,667,039 shares after the June 18 sale and 9,617,039 shares after the June 22 sale, indicating the sales were a small portion of the reported indirect position. Separate holding entries show 1,305,650 shares held by a Warren B. Kanders Roth IRA, 23,450 shares held by an Allison Kanders Roth IRA, and 22,888 shares held directly, all as of June 18. Footnotes state Kanders is the sole manager and member of Kanders SAF, LLC and that he disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.43%
Tags
insider
Rhea-AI Summary

Cadre Holdings, Inc. director Mary E. Kissel received a grant of stock options for 17,393 shares of common stock. The options have an exercise price of $28.75 per share and expire on June 16, 2036, functioning as equity-based compensation rather than an open-market purchase.

These options were granted under the company’s 2021 Stock Incentive Plan. They vest in four installments: 4,349 shares on June 30, 2026, and 4,348 shares on each of September 30, 2026, December 31, 2026, and March 31, 2027. All holdings reported are direct.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.44%
Tags
insider

FAQ

How many Cadre Holdings (CDRE) SEC filings are available on StockTitan?

StockTitan tracks 82 SEC filings for Cadre Holdings (CDRE), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Cadre Holdings (CDRE)?

The most recent SEC filing for Cadre Holdings (CDRE) was filed on November 16, 2026.